Incannex Healthcare(IXHL.US)

Last Updated 19:00:00 ET
longbridge loading

Incannex Healthcare | 10-Q: FY2026 Q3 Revenue: USD 0

Earnings Watch·
US
IXHL
-2.16%
Earnings Watch·
US
IXHL
-2.16%

Incannex Healthcare Inc. 1Q 2026: Revenue $0.09M, EPS $(0.35) — 10-Q Summary

TradingView·
US
IXHL
-2.16%
US
IXJ
+0.71%
US
XBI
+0.77%
TradingView·
US
IXHL
-2.16%
US
IXJ
+0.71%
US
XBI
+0.77%

Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea | IXHL Stock News

StockTitan·
US
IXHL
-2.16%
US
XLV
+0.67%
US
SBIO
+1.80%
StockTitan·
US
IXHL
-2.16%
US
XLV
+0.67%
US
SBIO
+1.80%

Incannex Highlights Psilocybin Anxiety Program Amid U.S. Policy Shift

Tip Ranks·
US
IXHL
-2.16%
US
XBI
+0.77%
US
VHT
+0.63%
Tip Ranks·
US
IXHL
-2.16%
US
XBI
+0.77%
US
VHT
+0.63%

Incannex Healthcare aligns PSX-001 program with White House order, cites strong Phase 2 data and $70M cash

TradingView·
US
IXHL
-2.16%
US
PSIL
+3.01%
TradingView·
US
IXHL
-2.16%
US
PSIL
+3.01%

Psychedelic drug stocks are surging after Trump's order to fast-track development for medical use

businessinsider·
US
CMPS
+5.52%
US
SILO
+4.67%
US
HELP
+6.45%
businessinsider·
US
CMPS
+5.52%
US
SILO
+4.67%
US
HELP
+6.45%

Incannex Reactivates Share Buyback, Signaling Valuation Confidence

Tip Ranks·
US
IXJ
+0.71%
US
PBE
+0.56%
US
BIB
+0.08%
Tip Ranks·
US
IXJ
+0.71%
US
PBE
+0.56%
US
BIB
+0.08%
© 2026 Longbridge｜Disclaimer